CASI Pharmaceuticals Inc

NASDAQ:CASI   3:59:57 PM EDT
1.99
+0.08 (+4.19%)
5:52:22 PM EDT: $2.03 +0.04 (+2.01%)
Earnings Announcements

Casi Pharmaceuticals Announces Third Quarter 2022 Financial Results

Published: 11/14/2022 13:04 GMT
CASI Pharmaceuticals Inc (CASI) - Casi Pharmaceuticals Announces Third Quarter 2022 Financial Results.
Casi Pharmaceuticals - Revenue Was $10.2 Million for Three Months Ended September 30, 2022, Compared to $8.1 Million for Three Months Ended September 30, 2021.
Casi Pharmaceuticals Inc Qtrly Net Loss per Share (basic and Diluted) $0.38.
Revenue is expected to be $10.81 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $9.1 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.